-
1
-
-
60849106348
-
Ethical and scientific implications of the globalization of clinical research
-
S.W. Glickman, J.G. McHutchison, E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
-
(2009)
N Engl J Med
, vol.360
, pp. 816-823
-
-
Glickman, S.W.1
McHutchison, J.G.2
Peterson, E.D.3
-
2
-
-
84867183673
-
The prevention and treatment of missing data in clinical trials
-
R.J. Little, R. D'Agostino, M.L. Cohen The prevention and treatment of missing data in clinical trials N Engl J Med 367 2012 1355 1360
-
(2012)
N Engl J Med
, vol.367
, pp. 1355-1360
-
-
Little, R.J.1
D'Agostino, R.2
Cohen, M.L.3
-
3
-
-
84873095762
-
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: Insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial
-
J. Butler, H. Subacius, M. Vaduganathan Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial J Am Coll Cardiol 61 2013 571 579
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. 571-579
-
-
Butler, J.1
Subacius, H.2
Vaduganathan, M.3
-
4
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
-
M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, Jr.J.C.3
-
5
-
-
0034820167
-
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis Results from InTIME-II
-
R.P. Giugliano, J. Llevadot, R.G. Wilcox Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis Results from InTIME-II Eur Heart J 22 2001 1702 1715
-
(2001)
Eur Heart J
, vol.22
, pp. 1702-1715
-
-
Giugliano, R.P.1
Llevadot, J.2
Wilcox, R.G.3
-
6
-
-
84860390336
-
Influence of global region on outcomes in heart failure beta-blocker trials
-
C.M. O'Connor, M. Fiuzat, K. Swedberg Influence of global region on outcomes in heart failure beta-blocker trials J Am Coll Cardiol 58 2011 915 922
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 915-922
-
-
O'Connor, C.M.1
Fiuzat, M.2
Swedberg, K.3
-
7
-
-
0033981265
-
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes Results from PURSUIT
-
K.M. Akkerhuis, J.W. Deckers, E. Boersma Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes Results from PURSUIT Eur Heart J 21 2000 371 381
-
(2000)
Eur Heart J
, vol.21
, pp. 371-381
-
-
Akkerhuis, K.M.1
Deckers, J.W.2
Boersma, E.3
-
8
-
-
71849108140
-
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes
-
D.J. Kumbhani, C.P. Cannon, G.C. Fonarow Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes JAMA 302 2009 2207 2213
-
(2009)
JAMA
, vol.302
, pp. 2207-2213
-
-
Kumbhani, D.J.1
Cannon, C.P.2
Fonarow, G.C.3
-
9
-
-
20944445209
-
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
-
M. Gheorghiade, C. Orlandi, J.C. Burnett Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Card Fail 11 2005 260 269
-
(2005)
J Card Fail
, vol.11
, pp. 260-269
-
-
Gheorghiade, M.1
Orlandi, C.2
Burnett, J.C.3
-
10
-
-
61449263596
-
Scientific evidence underlying the ACC/AHA clinical practice guidelines
-
P. Tricoci, J.M. Allen, J.M. Kramer, R.M. Califf, S.C. Smith Jr Scientific evidence underlying the ACC/AHA clinical practice guidelines JAMA 301 2009 831 841
-
(2009)
JAMA
, vol.301
, pp. 831-841
-
-
Tricoci, P.1
Allen, J.M.2
Kramer, J.M.3
Califf, R.M.4
Smith, Jr.S.C.5
-
11
-
-
79952260198
-
Diuretic strategies in patients with acute decompensated heart failure
-
G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
-
(2011)
N Engl J Med
, vol.364
, pp. 797-805
-
-
Felker, G.M.1
Lee, K.L.2
Bull, D.A.3
-
12
-
-
84866707415
-
Guided antithrombotic therapy: Current status and future research direction: Report on a national heart, lung and blood institute working group
-
V. Fuster, D.L. Bhatt, R.M. Califf Guided antithrombotic therapy: current status and future research direction: report on a national heart, lung and blood institute working group Circulation 126 2012 1645 1662
-
(2012)
Circulation
, vol.126
, pp. 1645-1662
-
-
Fuster, V.1
Bhatt, D.L.2
Califf, R.M.3
-
13
-
-
77953018430
-
Advancing the care of cardiac patients using registry data: Going where randomized clinical trials dare not
-
D.L. Bhatt Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not JAMA 303 2010 2188 2189
-
(2010)
JAMA
, vol.303
, pp. 2188-2189
-
-
Bhatt, D.L.1
-
14
-
-
33745644752
-
Interpreting observational studies - Look before you leap
-
A.A. Bavry, D.L. Bhatt Interpreting observational studies - look before you leap J Clin Epidemiol 59 2006 763 764
-
(2006)
J Clin Epidemiol
, vol.59
, pp. 763-764
-
-
Bavry, A.A.1
Bhatt, D.L.2
|